tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 181 are a BUY (70.43%), 56 are a HOLD (21.79%), 20 are a SELL (7.78%).
Analyst Andrew Berens, carries an average stock price target met ratio of 57.28% that have a potential upside of 38.29% achieved within 241 days. Previously, Andrew Berens worked at LEERINK.
Andrew Berens’s has documented 506 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ZYME, Zymeworks Common Stock at 03-Mar-2026.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Feb-2025
$65
$37.53 (136.62%)
$48
25 days ago
(12-Feb-2026)
0/4 (0%)
$36.93 (131.56%)
Hold Since 01-Dec-2022
$25
$-2.47 (-8.99%)
$20
2 months 3 days ago
(06-Jan-2026)
5/7 (71.43%)
$-2.47 (-8.99%)
181
Buy Since 20-Nov-2025
$40
$12.53 (45.61%)
$34
2 months 11 days ago
(26-Dec-2025)
11/16 (68.75%)
$11.98 (42.76%)
205
Buy Since 24-Nov-2025
$38
$10.53 (38.33%)
$32
2 months 13 days ago
(24-Dec-2025)
6/9 (66.67%)
$8.83 (30.27%)
71
Buy Since 03-Dec-2021
$34
$6.53 (23.77%)
$32
2 months 13 days ago
(24-Dec-2025)
6/14 (42.86%)
$4.83 (16.56%)
477
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?
